Clinical Leader - Helping clinical research professionals connect and collaborate

consultation, examination result, electronic prescription-GettyImages-1403523137

Paving The Way For Sites To Use Their Own Tech

The DTRA has released a detailed playbook to help clinical research sites use their own validated technology in sponsor-led trials. The "Bring Your Own Technology" (BYOT) model aims to reduce tech overload at sites, improve efficiency, and preserve regulatory compliance — starting with eConsent as its first use case.

GUEST COLUMNISTS

How An Australia-First Strategy Cut 63% From Our R&D Spend
Etira CEO Russell Hayward explains how conducting the company's early-stage trials in Australia has yielded big savings, shortened timelines, and produced FDA-ready data.
Imunon Talks Passionate PIs, Endpoint Selection In Frontline Ovarian Cancer Trials
IMUNON CEO Stacy Lindborg, Ph.D. details the company’s successes in site selection, as well as trial design and execution, in Phase 2 and 3 trials for IMNN-001, a frontline treatment for ovarian cancer.
Dear Pharma, The Creator Economy Is NOT Only For Beauty
Empactful Ventures CEO Denise N. Bronner has a message for pharma when it comes to influencer marketing: Adapt or become invisible. Here, she details the hazards of overlooking this powerful media channel.
2 Challenges In Designing A Clinical Trial Exploring Personalized Elimination Diets
Vibrant Wellness clinical coordinator Suzanne Barker, MS, RDN, LDN, CGP, discusses how they faced and resolved two key issues when conducting a food sensitivity clinical trial.
Accurate Diagnosis And Enrollment Criteria Improve Intracerebral Hemorrhage Research
CEO Marc Deschamps shares how ischemic stroke treatment has overshadowed that of intracerebral hemorrhage, negatively impacting recruitment for ICH clinical trials. To turn the tide, he advocates for accurate diagnoses, more specialized care, and less restrictive enrollment criteria.
Hey, What's The Big Idea? Patient Enrollment Utterly Reimagined, That's What
What do air traffic control, nuclear power plants, and aircraft carriers have in common? Patient recruitment expert Tatty Scott argues clinical researchers should look at these industries to inspire more precise trial execution.
Breaking Free From The Acronym Soup: Rethinking The Role Of Technology In Clinical Trials
Ascendis Pharma's Ivanna Rosendal details how clinical systems hinder clinical trial execution and why we should rethink how technology can support our trials.
Gilead Art Campaign Captures The PBC Patient Experience, Inspires Patient-Centric Trials
Gilead’s Carrie Frenette discusses the company's art campaign centered on primary biliary cholangitis to bring awareness to the condition and create more patient-centric trials for patients.

CLINICAL TRIAL WHITE PAPERS

2024 Market Trends In Clinical Trials: Navigating The Future With Ease
Explore this year’s market trends survey for a comprehensive analysis of the emerging trends, evolving preferences, and key challenges set to shape the future of clinical trial processes.

Closing The Gap In Our Understanding Of Sleep Health With DHTs
4/26/2024

This article delves into the current state of sleep assessments in clinical trials, advocates for a broader understanding of sleep, explores opportunities presented by wearable digital health technologies and examines regulatory expectations.
Navigating The European Market's Regulatory Complexities
12/30/2024

Prepare your EU launch strategy with this comprehensive guide detailing what is needed to ensure compliance and efficiency in the EU market.
Navigating The Evolving Landscape Of Immunotherapy in Oncology
3/17/2025

Immunotherapy is revolutionizing oncology, enhancing patient outcomes through targeted treatments. This evolving landscape includes checkpoint inhibitors, and personalized medicine, shaping the future of cancer care.
Decisions In Cell And Gene Therapy Development
7/2/2024

Explore critical decisions across clinical trial design, patient recruitment, site selection, logistics, manufacturing, and long-term follow-up, aiming to guide stakeholders through CAGT development.
Rare Disease – 2018-2022 Global Clinical Trial Landscape
11/7/2023

Discover why the collaboration and expertise of organizations are vital in advancing rare disease research and improving the lives of millions affected.

More Clinical Trial White Papers

CLINICAL TRIAL APP NOTES & CASE STUDIES

Breaking Free From Process Paralysis In Clinical Trials
1/13/2025

Explore the implementation of CRIO’s eSource solution by a leading pharmaceutical company to overcome process paralysis in clinical research.
Use Case: A Patient-Centric Approach To Site Selection
1/27/2025

Discover how Citeline’s robust datasets, combined with real-world data, inform intelligent site and investigator selection for a rare, autoimmune disease.
RTSM Manages Clinical IP Dispensation In Schizophrenia Study
8/30/2023

Challenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.
Treatment Benefits Of Wearable DHTs For Patients With Cancer Cachexia
11/20/2024

Wearable digital health technologies (DHTs) played a crucial role in assessing patient-centric outcomes during pfizer's study into the benefits of using ponsegromab for treating cancer cachexia.
Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments
1/15/2025

Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties
Blinded Randomization And Trial Supply Management Gets Support
11/17/2023

Uncover how this global specialty pharmaceutical company was able to ensure the confidentiality of its blinded study data while receiving flexible and scalable unblinded support.

More Clinical Trial App Notes & Case Studies

NEWSLETTER ARCHIVE

More Newsletters

RECRUITMENT AND DIVERSITY

This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.

Imunon Talks Passionate PIs, Endpoint Selection In Frontline Ovarian Cancer Trials

IMUNON CEO Stacy Lindborg, Ph.D. details the company’s successes in site selection, as well as trial design and execution, in Phase 2 and 3 trials for IMNN-001, a frontline treatment for ovarian cancer.
Dear Pharma, The Creator Economy Is NOT Only For Beauty

Empactful Ventures CEO Denise N. Bronner has a message for pharma when it comes to influencer marketing: Adapt or become invisible. Here, she details the hazards of overlooking this powerful media channel.
Accurate Diagnosis And Enrollment Criteria Improve Intracerebral Hemorrhage Research

CEO Marc Deschamps shares how ischemic stroke treatment has overshadowed that of intracerebral hemorrhage, negatively impacting recruitment for ICH clinical trials. To turn the tide, he advocates for accurate diagnoses, more specialized care, and less restrictive enrollment criteria.

FOCUS ON PATIENTS

More Personalized, Precision Medicine Needed In Psychiatry Clinical Trials

Arrivo Bioventures' Joel Raskin, MD, and Greg Rigdon, Ph.D., discuss the importance of personalized and precision medicine in psychiatry clinical trials.
From Protocol To People: Teva's Patient-First Clinical Trials Approach

Teva Pharmaceuticals' Head of Global Early Clinical Development Eran Harary, MD, shares how the company approaches drug development by getting patient input early and often.
2 Challenges In Designing A Clinical Trial Exploring Personalized Elimination Diets

Vibrant Wellness clinical coordinator Suzanne Barker, MS, RDN, LDN, CGP, discusses how they faced and resolved two key issues when conducting a food sensitivity clinical trial.